MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D8A524.B202C000"

Данный документ является веб-страницей в одном файле, также называемой файлом веб-архива. Если вы видите это сообщение, значит, данный браузер или редактор не поддерживает файлы веб-архива. Загрузите браузер, поддерживающий веб-архивы, например Windows® Internet Explorer®.

------=_NextPart_01D8A524.B202C000
Content-Location: file:///C:/68119331/UA91010101_AC81.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link rel=3DFile-List href=3D"UA91010101_AC81.files/filelist.xml">
<link rel=3DPreview href=3D"UA91010101_AC81.files/preview.wmf">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Mayarovska, Tatyana</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Bravada</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:LastPrinted>2018-05-03T11:10:00Z</o:LastPrinted>
  <o:Created>2022-07-31T18:30:00Z</o:Created>
  <o:LastSaved>2022-07-31T18:30:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>1375</o:Words>
  <o:Characters>7838</o:Characters>
  <o:Company>SPecialiST RePack</o:Company>
  <o:Lines>65</o:Lines>
  <o:Paragraphs>18</o:Paragraphs>
  <o:CharactersWithSpaces>9195</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:RelyOnVML/>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"UA91010101_AC81.files/item0001.xml"
target=3D"UA91010101_AC81.files/props002.xml">
<link rel=3DthemeData href=3D"UA91010101_AC81.files/themedata.thmx">
<link rel=3DcolorSchemeMapping href=3D"UA91010101_AC81.files/colorschememap=
ping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>RU</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"true"
  DefSemiHidden=3D"true" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"267">
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" Name=3D"footer"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" QFormat=3D"true" Name=3D=
"caption"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" Name=3D"Default Paragraph=
 Font"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" Name=3D"Body Text Indent"=
/>
  <w:LsdException Locked=3D"false" Priority=3D"11" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" Name=3D"Normal (Web)"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Placeho=
lder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Revisio=
n"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" QFormat=3D"true" Name=3D=
"TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520092929 1073786111 9 0 415 0;}
@font-face
	{font-family:HiddenHorzOCR;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"MS Mincho";
	mso-font-charset:128;
	mso-generic-font-family:auto;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:0 134676480 16 0 131072 0;}
@font-face
	{font-family:TimesNewRoman;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"Yu Gothic";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:3 134676480 16 0 131073 0;}
@font-face
	{font-family:"Times New Roman CYR";
	panose-1:2 2 6 3 5 4 5 2 3 4;
	mso-font-charset:204;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711039 9 0 511 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520084737 -1073683329 41 0 479 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
@font-face
	{font-family:"\@HiddenHorzOCR";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:auto;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:0 134676480 16 0 131072 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-parent:"";
	margin-top:5.0pt;
	margin-right:0cm;
	margin-bottom:5.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
h1
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 1 Знак";
	mso-style-next:Обычный;
	margin-top:5.0pt;
	margin-right:0cm;
	margin-bottom:5.0pt;
	margin-left:0cm;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman CYR","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:0pt;
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-priority:99;
	mso-style-link:"Текст примечания Знак";
	margin-top:5.0pt;
	margin-right:0cm;
	margin-bottom:5.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-unhide:no;
	mso-style-link:"Нижний колонтитул Знак";
	margin-top:5.0pt;
	margin-right:0cm;
	margin-bottom:5.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	tab-stops:center 8.0cm right 16.0cm;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-unhide:no;
	mso-style-link:"Основной текст с отступом Знак";
	margin-top:5.0pt;
	margin-right:0cm;
	margin-bottom:5.0pt;
	margin-left:0cm;
	text-indent:27.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
p
	{mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Arial Unicode MS";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
tt
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	font-family:"Arial Unicode MS","sans-serif";
	mso-ascii-font-family:"Arial Unicode MS";
	mso-fareast-font-family:"Arial Unicode MS";
	mso-hansi-font-family:"Arial Unicode MS";
	mso-bidi-font-family:"Arial Unicode MS";}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"Текст примечания";
	mso-style-link:"Тема примечания Знак";
	mso-style-next:"Текст примечания";
	margin-top:5.0pt;
	margin-right:0cm;
	margin-bottom:5.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Текст выноски Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Segoe UI","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
span.MsoPlaceholderText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	color:gray;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:5.0pt;
	margin-right:0cm;
	margin-bottom:5.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParag=
raphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:5.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListPar=
agraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagra=
phCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:5.0pt;
	margin-left:36.0pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
span.1
	{mso-style-name:"Заголовок 1 Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 1";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman CYR","serif";
	mso-ascii-font-family:"Times New Roman CYR";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman CYR";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:both;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.a
	{mso-style-name:"Основной текст с отступом Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Основной текст с отступом";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:both;}
p.10, li.10, div.10
	{mso-style-name:"Обычный \(веб\)1\,Обычный \(Web\)";
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0cm;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Arial Unicode MS";
	mso-ansi-language:UK;
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:line;}
span.a0
	{mso-style-name:"Нижний колонтитул Знак";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Нижний колонтитул";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:both;}
span.a1
	{mso-style-name:"Основной текст_";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Основной текст2";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	background:white;}
p.2, li.2, div.2
	{mso-style-name:"Основной текст2";
	mso-style-unhide:no;
	mso-style-link:"Основной текст_";
	margin:0cm;
	margin-bottom:.0001pt;
	text-indent:-21.0pt;
	mso-line-height-alt:0pt;
	mso-pagination:none;
	background:white;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;
	mso-bidi-language:AR-SA;
	layout-grid-mode:both;}
span.a2
	{mso-style-name:"Текст выноски Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Текст выноски";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Segoe UI","sans-serif";
	mso-ascii-font-family:"Segoe UI";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Segoe UI";
	mso-bidi-font-family:"Segoe UI";
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:both;}
span.a3
	{mso-style-name:"Текст примечания Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Текст примечания";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:both;}
span.a4
	{mso-style-name:"Тема примечания Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Тема примечания";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:UK;
	mso-bidi-language:UK;
	layout-grid-mode:both;
	font-weight:bold;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:42.5pt 42.5pt 42.5pt 70.85pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:389311275;
	mso-list-template-ids:1230275732;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:•;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-variant:normal !important;
	color:black;
	position:relative;
	top:0pt;
	mso-text-raise:0pt;
	letter-spacing:0pt;
	mso-font-width:100%;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;
	mso-bidi-language:EN-US;
	mso-ansi-font-weight:normal;
	mso-bidi-font-weight:normal;
	mso-ansi-font-style:normal;
	mso-bidi-font-style:normal;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;}
@list l0:level2
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level3
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level4
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level5
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level6
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level7
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level8
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l0:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l1
	{mso-list-id:404649810;
	mso-list-template-ids:-1245696322;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\25A0;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-variant:normal !important;
	color:black;
	position:relative;
	top:0pt;
	mso-text-raise:0pt;
	letter-spacing:0pt;
	mso-font-width:100%;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;
	mso-bidi-language:EN-US;
	mso-ansi-font-weight:normal;
	mso-bidi-font-weight:normal;
	mso-ansi-font-style:normal;
	mso-bidi-font-style:normal;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;}
@list l1:level2
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l1:level3
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l1:level4
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l1:level5
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l1:level6
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l1:level7
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l1:level8
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l1:level9
	{mso-level-start-at:0;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:0cm;}
@list l2
	{mso-list-id:1784306983;
	mso-list-type:hybrid;
	mso-list-template-ids:-632926230 68747265 69337091 69337093 69337089 69337=
091 69337093 69337089 69337091 69337093;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:1916551349;
	mso-list-type:hybrid;
	mso-list-template-ids:1174305116 68747265 68747267 68747269 68747265 68747=
267 68747269 68747265 68747267 68747269;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Обычная таблица";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-bidi-font-family:"Times New Roman";}
table.MsoTableGrid
	{mso-style-name:"Сетка таблицы";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:39;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-bidi-font-family:"Times New Roman";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DRU style=3D'tab-interval:35.4pt'>

<div class=3DWordSection1>

<p class=3DMsoNormal align=3Dcenter style=3D'margin:0cm;margin-bottom:.0001=
pt;
text-align:center'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial Unicode M=
S"'>ІНСТРУКЦІЯ<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin:0cm;margin-bottom:.0001=
pt;
text-align:center'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial Unicode M=
S"'>для
медичного застосування лікарського засобу<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin:0cm;margin-bottom:.0001=
pt;
text-align:center'><b><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
mso-fareast-font-family:"Arial Unicode MS"'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin:0cm;margin-bottom:.0001=
pt;
text-align:center'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:FR;mso-bidi-languag=
e:
FR'>КРАПЛІ БЕРЕШ ПЛЮС<sup>®</sup><o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin:0cm;margin-bottom:.0001=
pt;
text-align:center'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial Unicode M=
S"'>(</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-fon=
t-size:
12.0pt;mso-ansi-language:FR;mso-fareast-language:FR;mso-bidi-language:FR'>B=
</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
12.0pt;mso-fareast-language:FR;mso-bidi-language:FR'>&Eacute;</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-fon=
t-size:
12.0pt;mso-ansi-language:FR;mso-fareast-language:FR;mso-bidi-language:FR'>R=
ES
DROPS PLUS</span></b><b style=3D'mso-bidi-font-weight:normal'><sup><span la=
ng=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:FR;mso-bidi-languag=
e:
FR'>®</span></sup></b><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial Unicode M=
S"'>) <o:p></o:p></span></b></p>

<p class=3D10 style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'=
><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:9.0pt;font-family:"T=
imes New Roman","serif"'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=3D10 style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'=
><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:9.0pt;font-family:"T=
imes New Roman","serif"'>Склад:</span></i></b><b
style=3D'mso-bidi-font-weight:normal'><i><span lang=3DUK style=3D'font-size=
:12.0pt;
font-family:"Times New Roman","serif"'><o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial=
 Unicode MS";
mso-fareast-language:RU;mso-bidi-language:AR-SA;layout-grid-mode:both'>діючі
речовини:</span></i><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-=
fareast-font-family:
"Arial Unicode MS";mso-fareast-language:RU;mso-bidi-language:AR-SA;layout-g=
rid-mode:
both;mso-bidi-font-style:italic'> <span style=3D'mso-bidi-font-weight:bold'=
>1 мл
(18 крапель) містить: молібдену 0,1902 мг (у вигляді амонію молібдату
тетрагідрату 0,35 мг); ванадію 0,1219 мг (</span></span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:RU;mso-bidi-languag=
e:
AR-SA;layout-grid-mode:both;mso-bidi-font-weight:bold'>у вигляді амонію
монованадату 0,28 мг); бору 0,1049 мг (у вигляді кислоти борної 0,6 мг);</s=
pan><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial=
 Unicode MS";
mso-fareast-language:RU;mso-bidi-language:AR-SA;layout-grid-mode:both;
mso-bidi-font-weight:bold;mso-bidi-font-style:italic'> </span><span lang=3D=
UK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:RU;mso-bidi-languag=
e:
AR-SA;layout-grid-mode:both;mso-bidi-font-weight:bold'>кобальту 0,0248 мг (у
вигляді кобальту (ІІ) хлориду гексагідрату 0,1 мг)</span><span lang=3DHU
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU;mso-fareast-languag=
e:
RU;mso-bidi-language:AR-SA;layout-grid-mode:both;mso-bidi-font-weight:bold'=
>;</span><span
lang=3DHU style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:RU;mso-bi=
di-language:
AR-SA;layout-grid-mode:both;mso-bidi-font-weight:bold'> <span
style=3D'mso-spacerun:yes'> </span></span><span lang=3DUK style=3D'mso-bidi=
-font-size:
12.0pt;mso-fareast-language:RU;mso-bidi-language:AR-SA;layout-grid-mode:bot=
h;
mso-bidi-font-weight:bold'>міді 0,2545 мг (у вигляді міді сульфату пентагід=
рату
1 мг); заліза 2,009 мг (у вигляді заліза (ІІ) сульфату гептагідрату 10 мг);
магнію 0,4044 мг (у вигляді магнію сульфату гептагідрату 4,1 мг)</span><span
lang=3DHU style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU;mso-farea=
st-language:
RU;mso-bidi-language:AR-SA;layout-grid-mode:both;mso-bidi-font-weight:bold'=
>;</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:RU;mso-bi=
di-language:
AR-SA;layout-grid-mode:both;mso-bidi-font-weight:bold'> марганцю 0,3055 мг =
(у
вигляді марганцю сульфату моногідрату 0,94 мг); нікелю 0,1087 мг (у вигляді
нікелю (ІІ) сульфату гексагідрату 0,4865 мг); фтору 0,0904 мг (у вигляді на=
трію
фториду 0,2 мг)</span><span lang=3DHU style=3D'mso-bidi-font-size:12.0pt;
mso-ansi-language:HU;mso-fareast-language:RU;mso-bidi-language:AR-SA;
layout-grid-mode:both;mso-bidi-font-weight:bold'>;</span><span lang=3DHU
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:RU;mso-bidi-languag=
e:
AR-SA;layout-grid-mode:both;mso-bidi-font-weight:bold'> </span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:RU;mso-bidi-languag=
e:
AR-SA;layout-grid-mode:both;mso-bidi-font-weight:bold'>цинку 1,137 мг (у
вигляді цинку сульфату гептагідрату 5 мг)</span><span lang=3DHU style=3D'ms=
o-bidi-font-size:
12.0pt;mso-ansi-language:HU;mso-fareast-language:RU;mso-bidi-language:AR-SA;
layout-grid-mode:both;mso-bidi-font-weight:bold'>;</span><i><span lang=3DHU
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial Unicode M=
S";
mso-ansi-language:HU;mso-fareast-language:RU;mso-bidi-language:AR-SA;
layout-grid-mode:both'><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;mso-fareast-font-family:"Arial Unicode MS";mso-fareast-language:RU;
mso-bidi-language:AR-SA;layout-grid-mode:both'>допоміжні речовини:</span></=
i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial=
 Unicode MS";
mso-fareast-language:RU;mso-bidi-language:AR-SA;layout-grid-mode:both'> глі=
церин
(85 %), динатрію едетат, гліцин, кислота янтарна, кислота аскорбінова, кисл=
ота
винна, натрію-калію тартрат, кислота сірчана, вода очищена.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK>Лікарська форма. </sp=
an></b><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial=
 Unicode MS";
mso-bidi-font-weight:bold'>Краплі оральні</span><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;mso-fareast-font-family:"Arial Unicode MS"'>.</span><span lang=3DUK
style=3D'mso-bidi-font-size:14.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK>Основні фізико-хімічні
властивості: </span></i><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
mso-bidi-font-weight:bold'>прозорий, водний розчин світло-зеленого або
жовтувато-зеленого кольору, без осаду. </span><i style=3D'mso-bidi-font-sty=
le:
normal'><span lang=3DUK><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DHU style=3D'mso-ansi-lan=
guage:
HU'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK>Фармакотерапевтична г=
рупа.</span></b><span
lang=3DUK> <span style=3D'mso-bidi-font-weight:bold'>Інші препарати мінерал=
ів. Код
АТ</span></span><span lang=3DEN-US style=3D'mso-ansi-language:EN-US;mso-bid=
i-font-weight:
bold'>X</span><span lang=3DUK style=3D'mso-bidi-font-weight:bold'> А12С Х.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK>Фармакологічні властивості.<span style=3D'mso-bidi-font-weight:bo=
ld;
mso-bidi-font-style:italic'><o:p></o:p></span></span></i></b></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt'>Фармакодинаміка<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>Лікарський засіб</span><span lang=3DUK style=3D'font-size:10.0pt;fon=
t-family:
HiddenHorzOCR;mso-hansi-font-family:Calibri;mso-bidi-font-family:HiddenHorz=
OCR;
mso-ansi-language:HU;mso-fareast-language:HU;mso-bidi-language:AR-SA;
layout-grid-mode:both'> </span><span lang=3DUK style=3D'mso-bidi-font-size:=
12.0pt;
mso-fareast-language:EN-US;mso-bidi-language:EN-US'>містить водний розчин м=
інеральних
сполук і мікроелементів, включених за допомогою координаційних зв’язків у
молекули органічних речовин. Мікроелементи відіграють важливу роль у підтри=
мці
біологічної рівноваги організму. Більшість із них насамперед знаходяться у
клітинах у вигляді кофакторів ферментів, забезпечуючи їх каталітичну
активність, а також стабілізацію структур макромолекул неферментного типу т=
а нормалізацію
рівня вітамінів і гормонів в організмі людини. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>Дефіцит мікроелементів може також розвинутись і у здорових людей, на=
приклад
у певному віці (підлітки, люди похилого віку) або у результаті використання
більшої кількості мікроелементів під час особливих фізіологічних станів (в
період вагітності або годування груддю). Деякі захворювання і методи лікува=
ння
також є частими причинами недостатності мікроелементів, що призводить до рі=
зних
клінічних симптомів. Навіть незначний дефіцит мікроелементів може мати
негативний вплив на стан імунної системи, фізичний стан, загальний стан,
одужання та відновлення після хвороби або хірургічного втручання. Краплі Бе=
реш Плюс<sup>®
</sup>містять найважливіші мікроелементи. Мета застосування препарату поляг=
ає у
забезпеченні потреб організму в мікроелементах, які не можуть бути застосов=
ані
в інших лікарських формах для перорального застосування.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt'>Фармакокінетика</span><span lang=3DUK><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify;
tab-stops:460.7pt'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-f=
areast-language:
EN-US;mso-bidi-language:EN-US'>Активні речовини лікарського</span><span
lang=3DUK style=3D'font-size:11.0pt;font-family:HiddenHorzOCR;mso-hansi-fon=
t-family:
Calibri;mso-bidi-font-family:HiddenHorzOCR;mso-ansi-language:HU;mso-fareast=
-language:
HU;mso-bidi-language:AR-SA;layout-grid-mode:both'> </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso-bidi-lang=
uage:
EN-US'>засобу</span><span lang=3DUK style=3D'font-size:11.0pt;font-family:H=
iddenHorzOCR;
mso-hansi-font-family:Calibri;mso-bidi-font-family:HiddenHorzOCR;mso-ansi-l=
anguage:
HU;mso-fareast-language:HU;mso-bidi-language:AR-SA;layout-grid-mode:both'> =
</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>Краплі Береш Плюс<sup>®</sup> добре всмоктуються зі шлунково-кишково=
го
тракту, тому їх біологічне застосування забезпечене. </span><span
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:RU;mso-fareast-languag=
e:
EN-US;mso-bidi-language:EN-US'>Фармакокінетичні дослідження були проведені з
використанням ізотопних методів у собак. Затримка мікроелементів в організм=
і в цілому
через 72 </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fare=
ast-language:
EN-US;mso-bidi-language:EN-US'>годин</span><span lang=3DHU style=3D'mso-bid=
i-font-size:
12.0pt;mso-ansi-language:HU;mso-fareast-language:EN-US;mso-bidi-language:EN=
-US'>i</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'> показує, що засвоєння мікроелементів було та</span><span
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:RU;mso-fareast-languag=
e:
EN-US;mso-bidi-language:EN-US'>к</span><span lang=3DUK style=3D'mso-bidi-fo=
nt-size:
12.0pt;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>им</span><span
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:RU;mso-fareast-languag=
e:
EN-US;mso-bidi-language:EN-US'>: </span><span lang=3DUK style=3D'mso-bidi-f=
ont-size:
12.0pt;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>дуже високе для
заліза </span><span style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:RU;
mso-fareast-language:EN-US;mso-bidi-language:EN-US'>(~30 </span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso-bidi-lang=
uage:
EN-US'>% від затримки мікроелементів в організмі в цілому</span><span
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:RU;mso-fareast-languag=
e:
EN-US;mso-bidi-language:EN-US'>); високе для цинку (~ 5 </span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso-bidi-lang=
uage:
EN-US'>%</span><span style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:R=
U;
mso-fareast-language:EN-US;mso-bidi-language:EN-US'>), </span><span lang=3D=
UK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso-bidi-lang=
uage:
EN-US'>кобальту</span><span style=3D'mso-bidi-font-size:12.0pt;mso-ansi-lan=
guage:
RU;mso-fareast-language:EN-US;mso-bidi-language:EN-US'> (~ 6 </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>%</span><span style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:R=
U;
mso-fareast-language:EN-US;mso-bidi-language:EN-US'>) і молібдену (~ 4 %); =
</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>відносно низьке для марганцю</span><span style=3D'mso-bidi-font-size=
:12.0pt;
mso-ansi-language:RU;mso-fareast-language:EN-US;mso-bidi-language:EN-US'> (=
~ 2 </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>%</span><span style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:R=
U;
mso-fareast-language:EN-US;mso-bidi-language:EN-US'>) </span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso-bidi-lang=
uage:
EN-US'>і нікелю </span><span style=3D'mso-bidi-font-size:12.0pt;mso-ansi-la=
nguage:
RU;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>(~1 </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>%</span><span style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:R=
U;
mso-fareast-language:EN-US;mso-bidi-language:EN-US'>).</span><span lang=3DHU
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU;mso-fareast-languag=
e:
EN-US;mso-bidi-language:EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify;
mso-pagination:none;tab-stops:17.3pt'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
12.0pt;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>Відповідно до
існуючих доклінічних даних клінічне застосування препарату є безпечним.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK><o:p>&nbsp;</o:p></spa=
n></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-layout-grid-align:none;
text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
UK>Клінічні
характеристики.</span></b><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t'><o:p></o:p></span></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:9.0pt;font-family:"T=
imes New Roman","serif"'>Показання.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt;text-=
align:
justify'><span style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:RU;
mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>Дефіцит мікроелементів
або патологічні</span><span style=3D'mso-bidi-font-size:12.0pt;mso-bidi-fon=
t-weight:
bold;mso-bidi-font-style:italic'> </span><span style=3D'mso-bidi-font-size:=
12.0pt;
mso-ansi-language:RU;mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>=
стани,</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-bidi-font-weight:bold;mso-=
bidi-font-style:
italic'> при яких необхідне додаткове застосування мінеральних речовин:<o:p=
></o:p></span></p>

<ul style=3D'margin-top:0cm' type=3Ddisc>
 <li class=3DMsoNormal style=3D'margin-top:0cm;margin-bottom:0cm;margin-bot=
tom:
     .0001pt;text-align:justify;mso-list:l3 level1 lfo1'><span lang=3DUK
     style=3D'mso-bidi-font-size:12.0pt'>для підтримки діяльності імунної
     системи, опірності організму або у випадках зниження останньої, наприк=
лад,
     при застуді, грипі;<o:p></o:p></span></li>
 <li class=3DMsoNormal style=3D'margin-top:0cm;margin-bottom:0cm;margin-bot=
tom:
     .0001pt;text-align:justify;mso-list:l3 level1 lfo1'><span lang=3DUK
     style=3D'mso-bidi-font-size:12.0pt'>у разі недостатнього харчування
     (наприклад, спеціальні дієти, у тому числі дієти для схуднення, у разі
     вегетаріанського харчування), а також при підвищеному фізичному
     навантаженні;<o:p></o:p></span></li>
 <li class=3DMsoNormal style=3D'margin-top:0cm;margin-bottom:0cm;margin-bot=
tom:
     .0001pt;text-align:justify;mso-list:l3 level1 lfo1'><span lang=3DUK
     style=3D'mso-bidi-font-size:12.0pt'>у разі підвищеної втомлюваності,
     відсутності апетиту, млявості, слабкості, безсоння, а також для
     прискорення реабілітації після захворювань, хірургічних втручань;<o:p>=
</o:p></span></li>
 <li class=3DMsoNormal style=3D'margin-top:0cm;margin-bottom:0cm;margin-bot=
tom:
     .0001pt;text-align:justify;mso-list:l3 level1 lfo1'><span lang=3DUK
     style=3D'mso-bidi-font-size:12.0pt'>як додаткова терапія для поліпшення
     загального стану і самопочуття пацієнтів з онкологічними захворюванням=
и.<o:p></o:p></span></li>
</ul>

<p class=3DMsoCommentText style=3D'margin-left:36.0pt'><span style=3D'mso-b=
idi-font-size:
12.0pt;mso-ansi-language:RU'><o:p>&nbsp;</o:p></span></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:9.0pt;font-family:"T=
imes New Roman","serif"'>Протипоказання.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>Підвищен</span><span lang=3DHU
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU'>a</span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt'> чутлив</span><span lang=3DHU style=3D'=
mso-bidi-font-size:
12.0pt;mso-ansi-language:HU'>i</span><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt'>ст</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-far=
east-language:
EN-US;mso-bidi-language:EN-US'>ь</span><span lang=3DUK style=3D'mso-bidi-fo=
nt-size:
12.0pt'> до діючих речовин або до будь-яких допоміжних речовин (наприклад, =
алергія
на метали), тяжка ниркова недостатність, а також захворювання, пов’язані з
порушенням обміну заліза і міді (включаючи гемахроматоз, гемосидероз, хворо=
б</span><span
lang=3DHU style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU'>y</span>=
<span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'> Вільсона)</span><span lang=
=3DHU
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU'>.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK><o:p>&nbsp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK>Взаємодія з іншими лікарськими засобами та інші види взаємодій.<s=
pan
style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p></o:p><=
/span></span></i></b></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>Між застосуванням препарату Краплі Береш Плюс<sup>®</sup> і застосув=
анням
інши</span><span lang=3DHU style=3D'mso-bidi-font-size:12.0pt;mso-ansi-lang=
uage:
HU;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>x</span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso-bidi-lang=
uage:
EN-US'> лікарськи</span><span lang=3DHU style=3D'mso-bidi-font-size:12.0pt;
mso-ansi-language:HU;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>x<=
/span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'> засоб</span><span lang=3DHU style=3D'mso-bidi-font-size:12.0pt;mso-=
ansi-language:
HU;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>i</span><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso-bidi-lang=
uage:
EN-US'>в необхідно дотримуватися інтервалу не менше 1 години. Щоб уникнути
передозування або антагоністичних взаємодій, не слід застосовувати краплі
одночасно з іншими препаратами, що містять мікроелементи.</span><span lang=
=3DHU
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU;mso-fareast-languag=
e:
EN-US;mso-bidi-language:EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DHU style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU;mso-farea=
st-language:
EN-US;mso-bidi-language:EN-US'>Між застосуванням лікарських препаратів, що
містять пеніциламін, бісфосфонати, фторхінолони, тетрацикліни, і застосуван=
ням
лікарського препарату </span><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt;
mso-fareast-language:EN-US;mso-bidi-language:EN-US'>Краплі Береш Плюс<sup>®=
</sup>
має минути принаймні 2 години (унаслідок фізико-хімічної взаємодії може
змінитися всмоктуваність препарату).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>Не рекомендується приймати препарат разом з молоком або кавою, оскіл=
ьки
при цьому погіршується всмоктуваність його діючих речовин.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>При одночасному застосуванні антацидних препаратів, що містять алюмі=
ній,
кальцій, магній, знижується абсорбція заліза.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Arial Unicod=
e MS";
mso-bidi-font-weight:bold'>Особливості<span style=3D'mso-spacerun:yes'> 
</span>застосування.<o:p></o:p></span></i></h1>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:.45pt;margin-bott=
om:0cm;
margin-left:0cm;margin-bottom:.0001pt;text-align:justify'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso-bidi-lang=
uage:
EN-US'>Застосування з молоком або кавою не рекомендується через те, що при
цьому погіршується всмоктуваність його діючих речовин</span><span
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:RU;mso-fareast-languag=
e:
EN-US;mso-bidi-language:EN-US'>. При додаванні препарату в певні види чаю
розчин може потемнішати. </span><span lang=3DUK style=3D'mso-bidi-font-size=
:12.0pt;
mso-fareast-language:EN-US;mso-bidi-language:EN-US'>Таке явище безпечне</sp=
an><span
lang=3DHU style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU;mso-farea=
st-language:
EN-US;mso-bidi-language:EN-US'> i</span><span lang=3DHU style=3D'mso-bidi-f=
ont-size:
12.0pt;mso-fareast-language:EN-US;mso-bidi-language:EN-US'> </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>зумовлене вмістом таніну (дубильної кислоти), що міститься в чаї</sp=
an><span
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:RU;mso-fareast-languag=
e:
EN-US;mso-bidi-language:EN-US'>. При додаванні декількох крапель </span><sp=
an
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>лимонного соку</span><span style=3D'mso-bidi-font-size:12.0pt;mso-an=
si-language:
RU;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>, </span><span lang=
=3DUK>замінника
лимонного соку</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso=
-fareast-language:
EN-US;mso-bidi-language:EN-US'> або аскорбінової кислоти забарвлення не
відбувається</span><span style=3D'mso-bidi-font-size:12.0pt;mso-ansi-langua=
ge:
RU;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:.45pt;margin-bott=
om:0cm;
margin-left:0cm;margin-bottom:.0001pt;text-align:justify;mso-layout-grid-al=
ign:
none;text-autospace:none'><i style=3D'mso-bidi-font-style:normal'><span
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:TimesNewRoman;
mso-ansi-language:RU;layout-grid-mode:both'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:.45pt;margin-bott=
om:0cm;
margin-left:0cm;margin-bottom:.0001pt;text-align:justify;mso-layout-grid-al=
ign:
none;text-autospace:none'><i style=3D'mso-bidi-font-style:normal'><span
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:TimesNewRoman;
mso-ansi-language:RU;layout-grid-mode:both'>Застосування у пер</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;mso-fareast-font-family:TimesNewRoman;layout-grid-mode:both'>іод
вагітності та годування груддю<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-top:5.0pt;margin-right:.45pt;margin-bo=
ttom:
15.45pt;margin-left:0cm;text-align:justify;line-height:11.0pt;mso-line-heig=
ht-rule:
exactly'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-lan=
guage:
EN-US;mso-bidi-language:EN-US'>Під час вагітності та годування груддю лікар=
ськи
засіб можна застосовувати </span><span lang=3DHU style=3D'mso-bidi-font-siz=
e:12.0pt;
mso-ansi-language:HU;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>y<=
/span><span
lang=3DHU style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'> </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-farea=
st-language:
EN-US;mso-bidi-language:EN-US'>рекомендованих добових дозах (після консульт=
ації
з лікарем).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:.45pt;margin-bott=
om:0cm;
margin-left:0cm;margin-bottom:.0001pt;text-align:justify;mso-layout-grid-al=
ign:
none;text-autospace:none'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:TimesNewRoman;
layout-grid-mode:both'>Здатність впливати на швидкість реакції при керуванні
автотранспортом або іншими механізмами<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-top:5.0pt;margin-right:.45pt;margin-bo=
ttom:
15.65pt;margin-left:0cm;text-align:justify;line-height:11.0pt;mso-line-heig=
ht-rule:
exactly'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-lan=
guage:
EN-US;mso-bidi-language:EN-US'>При застосуванні в рекомендованих дозах ніяк=
ого
негативного впливу не спостерігається.<o:p></o:p></span></p>

<p class=3DMsoBodyTextIndent style=3D'margin:0cm;margin-bottom:.0001pt;text=
-align:
justify;text-indent:0cm'><b style=3D'mso-bidi-font-weight:normal'><i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial=
 Unicode MS"'>Спосіб
застосування та дози.</span></i></b><i><span lang=3DUK style=3D'mso-bidi-fo=
nt-size:
12.0pt;mso-fareast-font-family:"Arial Unicode MS"'> <o:p></o:p></span></i><=
/p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>Застосовувати внутрішньо під =
час їди.
Разову дозу крапель додавати до 50 мл рідини (наприклад води, фруктового со=
ку,
сиропу, фруктового чаю). Рекомендовано застосовувати разом з вітаміном С (50
мг) у кожен прийом препарату.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt'>У разі профілактичного застосування:<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt'>При масі тіла 10-20 кг – 5 крапель 2 ра=
зи на
добу.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt'>При масі тіла 20-40 кг – 10 крапель 2 р=
ази на
добу.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt'>При масі тіла понад 40 кг – 20 крапель =
2 рази
на добу.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt'>У разі застосування з метою лікування станів, перерахованих у
показаннях:<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt'>При масі тіла 10-20 кг – 10 крапель 2 р=
ази на
добу.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt'>При масі тіла 20-40 кг – 20 крапель 2 р=
ази на
добу.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt'>При масі тіла понад 40 кг – 20 крапель =
3 рази
на добу.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>У разі застосування для поліп=
шення
загального стану і самопочуття пацієнтів із онкологічними захворюваннями, м=
аса
тіла яких перевищує 40 кг, за рекомендацією лікаря можуть бути застосовані
добові дози, що перевищують вищезгадані, але не більше 120 крапель на добу.=
 У
таких випадках добову дозу рекомендується розподілити на 4-5 прийомів у рів=
них
частинах.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>У разі застосування препарату=
 з метою
профілактики у рекомендованих дозах досягнення оптимального ефекту очікуєть=
ся
приблизно через 6 тижнів безперервної терапії. Ця дія при подальшому
застосуванні препарату у профілактичних дозах може підтримуватися протягом
бажаного періоду (наприклад, у період зимових катаральних і грипозних
захворювань).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>Препарат застосовувати безпер=
ервно у
рекомендованих дозах при наявності симптомів захворювання.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>При повторному виникненні ска=
рг курс
лікування можна повторити.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>Тривалість лікування визначає=
 лікар
індивідуально.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt'>Діти<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>Препарат застосовувати дітям =
з масою
тіла більше 10 кг. Однак якщо маса тіла дитини менше 20 кг, питання про
застосування препарату вирішується індивідуально з педіатром, виходячи з оц=
інки
співвідношення користь/ризик для дитини.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt'><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK>Передозування.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;line-height:13.7pt;mso-lin=
e-height-rule:
exactly'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-lan=
guage:
EN-US;mso-bidi-language:EN-US'>Дослідження, проведене на здорових доброволь=
цях,
показало, що навіть доза </span><span style=3D'mso-bidi-font-size:12.0pt;
mso-ansi-language:RU;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>12=
0 </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'>крапель 3 рази на добу добре переноситься і є безпечною</span><span
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:RU;mso-fareast-languag=
e:
EN-US;mso-bidi-language:EN-US'>. Проте</span><span lang=3DUK style=3D'mso-b=
idi-font-size:
12.0pt;mso-fareast-language:EN-US;mso-bidi-language:EN-US'> при застосуванні
доз, що перевищують рекомендовані, можуть спостерігатися нудота та болі у
шлунку, що швидко минають. В окремих випадках </span><span style=3D'mso-bid=
i-font-size:
12.0pt;mso-ansi-language:RU;mso-fareast-language:EN-US;mso-bidi-language:EN=
-US'>можливі
алергічні реакції. У цьому випадку необхідно припинити застосування препара=
ту
та звернутися до лікаря.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b><i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial=
 Unicode MS"'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b><i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial=
 Unicode MS"'>Побічні
реакції.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:.7pt;margin-botto=
m:0cm;
margin-left:0cm;margin-bottom:.0001pt;text-align:justify'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso-bidi-lang=
uage:
EN-US'>Дуже рідко, головним чином якщо краплі приймати<span
style=3D'mso-spacerun:yes'>  </span>натщесерце або з меньшою, ніж рекомендо=
вано</span><span
lang=3DHU style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU;mso-farea=
st-language:
EN-US;mso-bidi-language:EN-US'>,</span><span lang=3DUK style=3D'mso-bidi-fo=
nt-size:
12.0pt;mso-fareast-language:EN-US;mso-bidi-language:EN-US'> кількістю рідин=
и,
можуть з’явитися легкі та тимчасові побічні реакції,</span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:HU;mso-fareast-languag=
e:
EN-US;mso-bidi-language:EN-US'> </span><span lang=3DUK style=3D'mso-bidi-fo=
nt-size:
12.0pt;mso-fareast-language:EN-US;mso-bidi-language:EN-US'>які наведено ниж=
че.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:.7pt;margin-botto=
m:0cm;
margin-left:0cm;margin-bottom:.0001pt;text-align:justify'><i style=3D'mso-b=
idi-font-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-lang=
uage:
EN-US;mso-bidi-language:EN-US'>З боку шлунково-кишкового тракту:</span></i>=
<span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso=
-bidi-language:
EN-US'> шлунково-кишкові розлади, включаючи слабко виражену нудоту, біль у
животі, запор, гіркий присмак в роті, забарвлення зубної емалі у дітей, що =
не
вимагають застосування будь-яких заходів і швидко минають.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-top:0cm;margin-right:.7pt;margin-botto=
m:0cm;
margin-left:0cm;margin-bottom:.0001pt;text-align:justify'><i style=3D'mso-b=
idi-font-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-lang=
uage:
EN-US;mso-bidi-language:EN-US'>З боку імунної системи:</span></i><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-language:EN-US;mso-bidi-lang=
uage:
EN-US'> реакції гіперчутливості.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
12.0pt;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;layout-grid-mode:
both'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK>Термін придатності.<o:p></o:p></span></i></b></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><span
style=3D'font-size:12.0pt;mso-bidi-font-size:9.0pt;font-family:"Times New R=
oman","serif";
mso-ansi-language:RU'>4 </span><span lang=3DUK style=3D'font-size:12.0pt;
mso-bidi-font-size:9.0pt;font-family:"Times New Roman","serif"'>роки. <o:p>=
</o:p></span></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><span lang=
=3DUK
style=3D'font-size:12.0pt;mso-bidi-font-size:9.0pt;font-family:"Times New R=
oman","serif"'>Після
першого відкриття флакона препарат придатний до застосування протягом 6
місяців.</span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times=
 New Roman","serif";
mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p></o:p></span></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp=
;</o:p></span></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-bidi-font-size:9.0pt;font-family:"Times New Roman","serif"'>Умови
зберігання.</span></b><b><span lang=3DUK style=3D'font-size:12.0pt;font-fam=
ily:
"Times New Roman","serif"'><o:p></o:p></span></b></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>Зберігати у
недоступному для дітей місці при температурі не вище 25 </span><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:Symbol;mso-ascii-font-family:"Times N=
ew Roman";
mso-hansi-font-family:"Times New Roman";mso-bidi-font-family:"Times New Rom=
an";
mso-char-type:symbol;mso-symbol-font-family:Symbol'><span style=3D'mso-char=
-type:
symbol;mso-symbol-font-family:Symbol'>°</span></span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>С.<o:p></o=
:p></span></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
<o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK>Упаковка. </span></b>=
<span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial=
 Unicode MS"'>По
30 мл або 100 мл у скляному флаконі з пробкою-крапельницею. По 1 флакону (3=
0 мл
або 100 мл) або по 4 флакони (30 мл) у картонній коробці.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Arial=
 Unicode MS"'><o:p>&nbsp;</o:p></span></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-bidi-font-size:9.0pt;font-family:"Times New Roman","serif"'>Категорія
відпуску.</span></b><b><span lang=3DUK style=3D'font-size:12.0pt;font-famil=
y:"Times New Roman","serif"'>
</span></b><span lang=3DUK style=3D'font-size:12.0pt;mso-bidi-font-size:9.0=
pt;
font-family:"Times New Roman","serif"'>Без рецепта.</span><b><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'><o:p></o:p=
></span></b></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
<o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK>Виробник. <o:p></o:p>=
</span></b></p>

<p class=3DMsoNormal style=3D'margin:0cm;margin-bottom:.0001pt;text-align:j=
ustify'><span
lang=3DUK>ЗАТ “Береш Фарма”<b style=3D'mso-bidi-font-weight:normal'><o:p></=
o:p></b></span></p>

<p style=3D'margin-top:0cm;margin-right:-8.25pt;margin-bottom:0cm;margin-le=
ft:
0cm;margin-bottom:.0001pt;text-align:justify'><b><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp=
;</o:p></span></b></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><b><span
lang=3DUK style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'>=
Місцезнаходження
виробника та його адреса місця провадження діяльності. <o:p></o:p></span></=
b></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-bidi-fo=
nt-weight:
bold'>500</span><span style=3D'font-size:12.0pt;font-family:"Times New Roma=
n","serif";
mso-ansi-language:RU;mso-bidi-font-weight:bold'>0</span><span lang=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif";mso-bidi-fo=
nt-weight:
bold'>, м. Сольнок, вул. Надьшандор Йожеф, б.39, Угорщина.</span><span lang=
=3DUK
style=3D'font-size:12.0pt;font-family:"Times New Roman","serif"'><o:p></o:p=
></span></p>

<p style=3D'margin:0cm;margin-bottom:.0001pt;text-align:justify'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-bidi-font-size:9.0pt;font-family:"Times New Roman","serif"'><o:p>&nbsp;=
</o:p></span></b></p>

</div>

</body>

</html>

------=_NextPart_01D8A524.B202C000
Content-Location: file:///C:/68119331/UA91010101_AC81.files/preview.wmf
Content-Transfer-Encoding: base64
Content-Type: image/x-wmf
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------=_NextPart_01D8A524.B202C000
Content-Location: file:///C:/68119331/UA91010101_AC81.files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<b:Sources SelectedStyle=3D"\APASixthEditionOfficeOnline.xsl" StyleName=3D"=
APA" Version=3D"6" xmlns:b=3D"http://schemas.openxmlformats.org/officeDocum=
ent/2006/bibliography" xmlns=3D"http://schemas.openxmlformats.org/officeDoc=
ument/2006/bibliography"></b:Sources>

------=_NextPart_01D8A524.B202C000
Content-Location: file:///C:/68119331/UA91010101_AC81.files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{5BCA3A4D-C64A-4C78-8D85-B09ACB9292EC}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D8A524.B202C000
Content-Location: file:///C:/68119331/UA91010101_AC81.files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D8A524.B202C000
Content-Location: file:///C:/68119331/UA91010101_AC81.files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D8A524.B202C000
Content-Location: file:///C:/68119331/UA91010101_AC81.files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../UA91010101_AC81.htm"/>
 <o:File HRef=3D"preview.wmf"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D8A524.B202C000--
